Miguel Barclay has built a reputation on proving that good food doesn’t need to cost more than £1 a portion. Now, he’s ...

His latest project, in collaboration with Novo Nordisk UK, is a collection of seven ... The takeaway is to swap white rice for brown, sugary cereals for oats and make fibre your best friend.

But as the drugstore chain (WBA) prepares to go private and its rival CVS Health Inc. (CVS) experiments with smaller stores, some analysts and researchers see a possible future with even fewer ...

Meanwhile Novo Nordisk has also seen its ranking surge ... Download the Productive Innovation Index white paper here. About the author: Andrew McConaghie is pharmaphorum's managing editor, feature ...

Rain sales on Big Tech stocks that overwhelm the Nasdaq but also infect the European lists. At Piazza Affari Buzzi and the ...

Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...

Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Roche agreed to develop a weight-loss drug with Danish biotech Zealand Pharma, pressuring Novo Nordisk and Eli Lilly.

In a report released today, Courtney Breen from Bernstein maintained a Hold rating on Novo Nordisk (0QIU – Research Report), with a price ...